Literature DB >> 11010824

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature.

T F Brewer1.   

Abstract

This article reviews a previously published meta-analysis of 1264 titles or abstracts and 70 selected studies for evaluation of the efficacy of bacillus Calmette-Guérin (BCG) vaccine in preventing tuberculosis. Following review, data from 26 studies were included in the analysis. These 26 studies reveal that vaccination with BCG significantly reduces the risk of tuberculosis by an average of 50%. This level of protection persists across a number of subgroups defined by age at vaccination and study design. Vaccination with BCG was significantly associated with a reduction in the incidence of pulmonary tuberculosis and extrapulmonary disease. In general, the results of this meta-analysis lend weight and confidence to arguments favoring the use of BCG vaccine.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11010824     DOI： 10.1086/314072

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  85 in total

Review 1.  [Immunization: leaps into the future. Tuberculosis vaccines].

Authors:  N Martínez Alsina; R Sastre de la Fuente
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

2.  Tuberculous meningitis: a disease of fatal outcome in children.

Authors:  Ibrahim M Khan; Samreen Khan; Ulrich Laaser
Journal:  Eur J Pediatr       Date:  2003-02-21       Impact factor: 3.183

3.  Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.

Authors:  Michael Santosuosso; Sarah McCormick; Xizhong Zhang; Anna Zganiacz; Zhou Xing
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.

Authors:  Ana M Aguirre-Blanco; Pauline T Lukey; Jacqueline M Cliff; Hazel M Dockrell
Journal:  Infect Immun       Date:  2007-03-26       Impact factor: 3.441

5.  Investigations of TB vaccine-induced mucosal protection in mice.

Authors:  Azra Blazevic; Christopher S Eickhoff; Jaime Stanley; Mark R Buller; Jill Schriewer; Eric M Kettelson; Daniel F Hoft
Journal:  Microbes Infect       Date:  2013-10-08       Impact factor: 2.700

6.  Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.

Authors:  Malcolm S Duthie; Rhea N Coler; John D Laurance; Lucas H Sampaio; Regiane M Oliveira; Ana Lucia M Sousa; Mariane M A Stefani; Yumi Maeda; Masanori Matsuoka; Masahiko Makino; Steven G Reed
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

7.  Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.

Authors:  Jason C O'Connor; Marcus A Lawson; Caroline André; Eileen M Briley; Sandra S Szegedi; Jacques Lestage; Nathalie Castanon; Miles Herkenham; Robert Dantzer; Keith W Kelley
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.

Authors:  Lihao Chen; Jun Wang; Anna Zganiacz; Zhou Xing
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Mycobacterium tuberculosis-Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4+ T Cell-Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the Airways.

Authors:  Jessica Jarvela; Michelle Moyer; Patrick Leahy; Tracey Bonfield; David Fletcher; Wambura N Mkono; Htin Aung; David H Canaday; Jean-Eudes Dazard; Richard F Silver
Journal:  J Immunol       Date:  2019-09-20       Impact factor: 5.422

10.  Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening.

Authors:  Katherine B Hisert; Meghan A Kirksey; James E Gomez; Alexandra O Sousa; Jeffery S Cox; William R Jacobs; Carl F Nathan; John D McKinney
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.